{"entity":{"type":"insider","cik":"0001405253","url":"/insider/0001405253","json_url":"/insider/0001405253.json","name":"Farrow Jeffrey S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2020-06-11","last":"2026-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Farrow Jeffrey S","source":"filing","n_filings":8,"first_seen":"2020-06-11","last_seen":"2026-06-17"}],"transactions":[{"id":5833570,"accession":"0001405253-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001405253-26-000013","line_url":"/filing/0001405253-26-000013#line-2","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14396.0,"shares_display":"14,396","price_per_share":60.95,"price_display":"60.95","price_state":"stated","total_value":877436.2,"total_display":"877,436.20","total_whole":"877,436","shares_owned_after":56801.0,"shares_owned_after_display":"56,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":6184003,"accession":"0001405253-26-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001405253-26-000007","line_url":"/filing/0001405253-26-000007#line-3","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2186.0,"shares_display":"2,186","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":146462.0,"total_display":"146,462.00","total_whole":"146,462","shares_owned_after":43316.0,"shares_owned_after_display":"43,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-19","scope":"insider"},{"id":6183999,"accession":"0001405253-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001405253-26-000007","line_url":"/filing/0001405253-26-000007#line-2","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2133.0,"shares_display":"2,133","price_per_share":68.71,"price_display":"68.71","price_state":"stated","total_value":146558.43,"total_display":"146,558.43","total_whole":"146,558","shares_owned_after":45502.0,"shares_owned_after_display":"45,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-19","scope":"insider"},{"id":6183995,"accession":"0001405253-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001405253-26-000007","line_url":"/filing/0001405253-26-000007#line-1","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2111.0,"shares_display":"2,111","price_per_share":69.42,"price_display":"69.42","price_state":"stated","total_value":146545.62,"total_display":"146,545.62","total_whole":"146,546","shares_owned_after":47635.0,"shares_owned_after_display":"47,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":4053451,"accession":"0001819790-25-000102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-25-000102","line_url":"/filing/0001819790-25-000102#line-2","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13608.0,"shares_display":"13,608","price_per_share":40.42,"price_display":"40.42","price_state":"stated","total_value":550035.36,"total_display":"550,035.36","total_whole":"550,035","shares_owned_after":36704.0,"shares_owned_after_display":"36,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-18","scope":"insider"},{"id":4077081,"accession":"0001819790-25-000054","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001819790-25-000054","line_url":"/filing/0001819790-25-000054#line-3","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1186.0,"shares_display":"1,186","price_per_share":50.11,"price_display":"50.11","price_state":"stated","total_value":59430.46,"total_display":"59,430.46","total_whole":"59,430","shares_owned_after":22431.0,"shares_owned_after_display":"22,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-20","scope":"insider"},{"id":4077078,"accession":"0001819790-25-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-25-000054","line_url":"/filing/0001819790-25-000054#line-2","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1254.0,"shares_display":"1,254","price_per_share":47.4,"price_display":"47.40","price_state":"stated","total_value":59439.6,"total_display":"59,439.60","total_whole":"59,440","shares_owned_after":23617.0,"shares_owned_after_display":"23,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":4077074,"accession":"0001819790-25-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001819790-25-000054","line_url":"/filing/0001819790-25-000054#line-1","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1284.0,"shares_display":"1,284","price_per_share":46.29,"price_display":"46.29","price_state":"stated","total_value":59436.36,"total_display":"59,436.36","total_whole":"59,436","shares_owned_after":24871.0,"shares_owned_after_display":"24,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":2832573,"accession":"0001819790-24-000089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001819790-24-000089","line_url":"/filing/0001819790-24-000089#line-2","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10445.0,"shares_display":"10,445","price_per_share":27.47,"price_display":"27.47","price_state":"stated","total_value":286924.15,"total_display":"286,924.15","total_whole":"286,924","shares_owned_after":18136.0,"shares_owned_after_display":"18,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":6670545,"accession":"0000899243-22-030475","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-030475","line_url":"/filing/0000899243-22-030475#line-4","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31441.0,"shares_display":"31,441","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":2137988.0,"total_display":"2,137,988.00","total_whole":"2,137,988","shares_owned_after":3086.0,"shares_owned_after_display":"3,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":2778679,"accession":"0000899243-20-019186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-019186","line_url":"/filing/0000899243-20-019186#line-1","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15208.0,"shares_display":"15,208","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":1140600.0,"total_display":"1,140,600.00","total_whole":"1,140,600","shares_owned_after":3048.0,"shares_owned_after_display":"3,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-15","scope":"insider"},{"id":3309817,"accession":"0000899243-20-016154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-016154","line_url":"/filing/0000899243-20-016154#line-1","is_derivative":false,"issuer_cik":"0001405253","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001405253","owner_cik":"0001405253","owner_name":"Farrow Jeffrey S","owner_display_name":"Farrow Jeffrey S","owner_url":"/insider/0001405253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15208.0,"shares_display":"15,208","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":1018936.0,"total_display":"1,018,936.00","total_whole":"1,018,936","shares_owned_after":18256.0,"shares_owned_after_display":"18,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Officer","n_filings":5,"first_seen":"2024-06-20","last_seen":"2026-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-06-11","last_seen":"2022-09-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405253","retrieved_at":"2026-08-23T22:14:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}